Relationship Between Red Cell Distribution Width (RDW) and HbA1C in Patients With Type 2 Diabetes Mellitus After Glycemic Control
New Valley University
250 participants
Dec 1, 2025
OBSERVATIONAL
Conditions
Summary
Diabetes mellitus (DM) is an epidemic disease, with approximately 463 million persons diagnosed with it. Of those, 90% are patients with type 2 DM (T2DM). Some estimates indicate that 700 million cases of DM will be reported in 2045. T2DM develops due to insulin resistance, leading to reduced insulin secretion. DM has a number of associated complications, such as nephropathy, neuropathy, and cardiovascular disease.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Blood test will be done at time of recruitment (for 2 groups) , after 3 months and after 6 months (for group 1 )
Blood test will be done at time of recruitment (for 2 groups) , after 3 months and after 6 months (for group 1 )
Blood test will be done at time of recruitment (for 2 groups) , after 3 months and after 6 months (for group 1 )
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06067399